{
  "nct_id": "NCT55623926",
  "indication": "Alzheimer's Disease",
  "phase": "Phase 3",
  "sample_size": 232,
  "duration_weeks": 50,
  "dropout_rate": 0.29,
  "primary_endpoints": [
    "Cognitive function"
  ],
  "secondary_endpoints": [
    "CDR-SB score",
    "Cognitive function"
  ],
  "blinding": "double-blind",
  "control_arm": "placebo",
  "outcome_summary": "Study met its primary endpoint with Cognitive function showing statistically significant improvement.",
  "success": true,
  "failure_reason": ""
}